High‐Yield Outer Membrane Vesicles Derived From Probiotics as a Nanoplatform for Precise Treatment and Prophylaxis of Pseudomonas aeruginosa Infection
Journal of Extracellular Vesicles · 2025-12 · 14 (12)
DOI: 10.1002/jev2.70194 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 08.12.2025. Verfasst von Yadong Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Crop Stress Resistance and High-Efficiency Production, Shaanxi Key Laboratory of Agricultural and Environmental Microbiology…. Hauptthemen laut MEDLINE: Probiotics, Pseudomonas aeruginosa, Pseudomonas Infections, Extracellular Vesicles. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Shaanxi Fundamental Science Research Project for Chemistry & Biology, Ningbo Top Medical and Health Research Program.
Abstract (Originalsprache)
Bacterial outer membrane vesicles (OMVs) are emerging as promising platforms for drug delivery and immunotherapy. However, bacteria only secrete a small amount of OMVs during the growth process, which seriously restricts their large‐scale application. Here, a series of high‐yield OMVs mutants is developed based on probiotic Escherichia coli Nissle 1917 (EcN). The mutant strain (EcNΔ tolR Δ mlaE ) with the highest OMVs yield reported so far is identified and characterized, and its OMVs yield is 180.8 times that of the wild‐type strain. More importantly, a high‐yield OMVs mutant (EcNΔ tolA Δ nlpI ) that derived OMVs can significantly improve the secretion efficiency of exogenous proteins is screened and engineered for enhanced scalability and versatility. Leveraging this platform, the prepared TOB‐PslG‐mOMVs nanoantibiotics, co‐delivering glycosyl hydrolase (PslG) and tobramycin (TOB), synergistically disrupt biofilms and demonstrate potent antibacterial effects against Pseudomonas aeruginosa . Additionally, the prepared FI‐mOMVs nanovaccines displaying the OprF 190‐342 ‐OprI 21‐83 antigenic epitope fusion protein (FI) of P. aeruginosa can effectively induce robust humoral immune and cellular immune responses and significantly enhance protection against bacterial infection. Therefore, the OMVs nanoplatform thus represents a transformative approach, opening new avenues for combating multi‐drug‐resistant bacteria through innovative nanoantibiotic and nanovaccine technologies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory for Crop Stress Resistance and High-Efficiency Production, Shaanxi Key Laboratory of Agricultural and Environmental Microbiology, College of Life Sciences, Northwest A&F University, Yangling, Shaanx…
- Ningbo Municipal Center for Disease Control and Prevention, Ningbo, Zhejiang, China.
ORCID-Profile: Xihui Shen
Förderung
- National Natural Science Foundation of China
- Shaanxi Fundamental Science Research Project for Chemistry & Biology
- Ningbo Top Medical and Health Research Program
Zitieren
APA
Yang, Y., Xu, L., Li, Y., Sun, Y., Tang, Y., Xiao, Z., Li, M., Chen, Y., Wang, Y., & Shen, X. (2025). High‐Yield Outer Membrane Vesicles Derived From Probiotics as a Nanoplatform for Precise Treatment and Prophylaxis of Pseudomonas aeruginosa Infection. Journal of Extracellular Vesicles, 14(12). https://doi.org/10.1002/jev2.70194
Vancouver
Yang Y, Xu L, Li Y, Sun Y, Tang Y, Xiao Z, et al. High‐Yield Outer Membrane Vesicles Derived From Probiotics as a Nanoplatform for Precise Treatment and Prophylaxis of Pseudomonas aeruginosa Infection. Journal of Extracellular Vesicles. 2025;14(12). doi:10.1002/jev2.70194
BibTeX
@article{Yang2025,
author = {Yang, Yadong and Xu, Lei and Li, Yongdong and Sun, Yu and Tang, Yanan and Xiao, Zhibo and Li, Mengyuan and Chen, Yi and Wang, Yao and Shen, Xihui},
title = {High‐Yield Outer Membrane Vesicles Derived From Probiotics as a Nanoplatform for Precise Treatment and Prophylaxis of Pseudomonas aeruginosa Infection},
journal = {Journal of Extracellular Vesicles},
year = {2025},
volume = {14},
number = {12},
doi = {10.1002/jev2.70194}
}
EUVIMED